GO:0043320 natural killer cell degranulation: Cytotoxic Secretory Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0043320 natural killer cell degranulation is the regulated exocytosis of secretory granules containing preformed mediators such as perforin and granzymes by a natural killer cell.
• Degranulation is the principal effector mechanism of NK cell-mediated cellular cytotoxicity and can be tracked by surface exposure of CD107a (LAMP-1).
• Rab27a activation, controlled by MADD, is required for NK cell degranulation, linking vesicle trafficking machinery to cytotoxic function.
• Cytokines such as IL-15 and IL-18, and tumor-derived factors such as butyrate, modulate NK cell degranulation and anti-tumor activity.
• Checkpoint molecules including CD155 and CAR engineering can enhance or restore NK cell degranulation against tumors.
• CRISPR knockout, point mutation, knock-in and overexpression models are essential to dissect the causal role of genes in NK cell degranulation.
Description
Natural killer (NK) cells are innate lymphoid cells that eliminate virally infected and transformed cells through directed secretion of cytotoxic granules, a process defined by the Gene Ontology term GO:0043320 natural killer cell degranulation. This biological process encompasses the regulated exocytosis of secretory granules containing preformed mediators such as perforin and granzymes by a natural killer cell. Because degranulation is the terminal effector step of NK cell-mediated cellular cytotoxicity, its accurate measurement and mechanistic dissection are central to immunology, cancer biology and immunotherapy research. The functional readout most widely used to quantify this process is surface exposure of CD107a (LAMP-1), which correlates with the release of cytotoxic granule contents. Beyond basic immunology, NK cell degranulation is a key variable in studies of tumor immunology, where microbial metabolites, cytokines and checkpoint blockade can tune the magnitude of the cytotoxic response. Consequently, researchers need robust models and methods to determine which genes causally regulate NK cell degranulation and how this process can be harnessed therapeutically.
natural killer cell degranulation At A Glance
| GO ID | GO:0043320 |
|---|---|
| GO term | natural killer cell degranulation |
| Ontology | biological_process |
| Synonym | natural killer cell granule exocytosis; NK cell degranulation; NK cell granule exocytosis |
| Definition | The regulated exocytosis of secretory granules containing preformed mediators such as perforin and granzymes by a natural killer cell. |
| Major function | Release of cytotoxic mediators to mediate NK cell-mediated cellular cytotoxicity |
| Cellular context | Natural killer cell secretory granules and plasma membrane |
| Key readout | Surface CD107a (LAMP-1) exposure as a marker of degranulation |
| Related processes | NK cell activation, cytotoxic granule trafficking, target cell killing |
What Is GO:0043320?
GO:0043320 natural killer cell degranulation is the regulated exocytosis of secretory granules containing preformed mediators such as perforin and granzymes by a natural killer cell. In other words, it is the process by which an NK cell fuses its cytotoxic granules with the plasma membrane and releases their contents to kill a target cell. The term is a biological_process in the Gene Ontology and is synonymous with natural killer cell granule exocytosis, NK cell degranulation and NK cell granule exocytosis.
Why Is natural killer cell degranulation Important in Cell Biology?
NK cell degranulation is the decisive effector step that allows NK cells to kill target cells, and its dysregulation directly affects immunity to tumors and pathogens. Because degranulation can be quantified by CD107a surface exposure, it serves as a functional biomarker of NK cell activity in both basic and clinical studies. Understanding the molecular control of this process, including Rab27a activation by MADD, provides mechanistic targets for enhancing NK cell cytotoxicity. Moreover, cytokines, microbial metabolites and checkpoint molecules can modulate degranulation, making it a central node in immuno-oncology and immunotherapy research.
• Defines the terminal cytotoxic effector function of NK cells against tumors and infected cells.
• Provides a measurable functional marker (CD107a) for NK cell activity in vitro and ex vivo.
• Links vesicle trafficking machinery, such as Rab27a and MADD, to immune cytotoxicity.
• Is modulated by cytokines including IL-15 and IL-18, affecting NK cell survival and function.
• Is influenced by tumor microenvironment factors such as butyrate and CXCL11-dependent NK cell infiltration.
• Can be enhanced by blockade of checkpoint molecules such as CD155.
• Is a functional endpoint improved by CAR engineering in NK cells.
• Serves as a key phenotype for CRISPR-based gene function studies in NK cells.
• Has implications for cancer immunotherapy, including hepatocellular carcinoma, glioblastoma and osteosarcoma.
• Is relevant to cryopreservation and manufacturing of NK cell products for therapy.
What Happens During natural killer cell degranulation?
Recognition and activation of the NK cell
In simple terms: The NK cell first recognizes a target cell and receives signals that tell it to attack.
NK cell-mediated cellular cytotoxicity begins with recognition of target cells through activating and inhibitory receptors, which sets the stage for directed secretion of cytotoxic granules. This recognition phase determines whether the NK cell will proceed to degranulation and kill the target.
Granule trafficking and Rab27a activation
In simple terms: Inside the cell, cytotoxic granules are moved to the right place with the help of molecular switches.
MADD regulates natural killer cell degranulation through activation of Rab27a, a small GTPase that controls secretory granule trafficking and exocytosis. This step ensures that cytotoxic granules are positioned for fusion with the plasma membrane.
Granule fusion and release of perforin and granzymes
In simple terms: The granules fuse with the outer membrane and release their killing payload.
Degranulation is the regulated exocytosis of secretory granules containing preformed mediators such as perforin and granzymes by a natural killer cell. Upon fusion, these mediators are released into the immunological synapse to induce target cell death.
CD107a exposure as a marker of degranulation
In simple terms: When granules fuse, a protein called CD107a appears on the cell surface, which scientists can measure.
CD107a (LAMP-1) becomes exposed on the NK cell surface upon granule fusion and serves as a functional marker for the identification of natural killer cell activity. This readout is widely used to quantify degranulation in response to target cells or stimuli.
Modulation by cytokines and tumor-derived factors
In simple terms: Signals from the environment can turn degranulation up or down.
Cytokines impact natural killer cell phenotype and functionality, including degranulation, against glioblastoma in vitro. Pretreatment with IL-15 and IL-18 rescues natural killer cells from granzyme B-mediated apoptosis after cryopreservation, supporting their functional capacity. The gut microbial metabolite butyrate suppresses hepatocellular carcinoma growth via CXCL11-dependent enhancement of natural killer cell infiltration, linking environmental metabolites to NK cell activity.
Key Genes Involved in GO:0043320 natural killer cell degranulation
The following genes and proteins are experimentally implicated in natural killer cell degranulation and its regulation, based on the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| PRF1 | Encodes perforin, a pore-forming mediator stored in cytotoxic granules | Core effector of NK cell degranulation and cytotoxicity |
| GZMB | Encodes granzyme B, a serine protease released during degranulation | Mediator of target cell apoptosis and cryopreservation-related apoptosis |
| LAMP1 | Encodes CD107a, a lysosomal/granule membrane protein exposed upon fusion | Functional marker of NK cell degranulation |
| RAB27A | Small GTPase controlling secretory granule trafficking and exocytosis | Required for NK cell degranulation; activated by MADD |
| MADD | Regulates NK cell degranulation through Rab27a activation | Mechanistic regulator of cytotoxic granule exocytosis |
| IL15 | Cytokine supporting NK cell survival and function | Pretreatment rescues NK cells from granzyme B-mediated apoptosis |
| IL18 | Cytokine that enhances NK cell functionality | Combined with IL-15 to improve NK cell function after cryopreservation |
| CXCL11 | Chemokine mediating NK cell infiltration | Butyrate enhances NK cell infiltration via CXCL11 in hepatocellular carcinoma |
| CD155 | Checkpoint ligand targeted to enhance NK cell antitumor response | CD155 blockade enhances allogeneic NK cell-mediated antitumor response |
| CAR | Chimeric antigen receptor engineered into NK cells | NK cell-specific CAR enhances CAR NK cell functions and anti-tumor activity |
| IFNG | Cytokine produced by activated NK cells | Associated with NK cell activation and function |
| NKG2D | Activating receptor on NK cells | Contributes to target cell recognition and activation |
| KIR | Inhibitory receptors regulating NK cell activation | Modulate the threshold for degranulation |
| CD16 | Fc receptor mediating antibody-dependent cellular cytotoxicity | Triggers NK cell degranulation in ADCC |
| LFA1 | Adhesion molecule facilitating immunological synapse formation | Supports directed granule secretion |
| MUNC13-4 | Priming factor for secretory granule fusion | General secretory machinery relevant to degranulation |
| STX11 | Syntaxin involved in granule fusion | Component of the exocytic machinery |
How Is natural killer cell degranulation Regulated?
Natural killer cell degranulation is regulated at multiple levels. MADD controls degranulation through activation of Rab27a, linking intracellular signaling to secretory granule exocytosis. Cytokines such as IL-15 and IL-18 modulate NK cell phenotype and functionality, and pretreatment with these cytokines rescues NK cells from granzyme B-mediated apoptosis after cryopreservation. Tumor microenvironment factors also regulate degranulation: the gut microbial metabolite butyrate suppresses hepatocellular carcinoma growth via CXCL11-dependent enhancement of natural killer cell infiltration, and CD155 blockade enhances allogeneic natural killer cell-mediated antitumor response. In addition, NK cell-specific chimeric antigen receptors enhance CAR NK cell functions and anti-tumor activity, indicating that engineered receptor signaling can boost degranulation.
natural killer cell degranulation and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| CXCL11 | Hepatocellular carcinoma; NK cell infiltration | Knockout or overexpression in NK cells or tumor models |
| CD155 | Osteosarcoma; allogeneic NK cell antitumor response | CD155 blockade with NK cell co-culture |
| GZMB | Cryopreservation-induced apoptosis in NK cells | IL-15/IL-18 pretreatment and apoptosis assays |
| CAR | Cancer immunotherapy; CAR NK cell function | NK cell-specific CAR knock-in |
| RAB27A | NK cell degranulation and cytotoxicity | Knockout or point mutation in NK cell lines |
Cancer immunotherapy and NK cell cytotoxicity
NK cell degranulation is central to anti-tumor immunity, and its enhancement is a therapeutic goal. The gut microbial metabolite butyrate suppresses hepatocellular carcinoma growth via CXCL11-dependent enhancement of natural killer cell infiltration, linking degranulation-related NK cell activity to tumor control. CD155 blockade enhances allogeneic natural killer cell-mediated antitumor response against osteosarcoma, demonstrating that checkpoint modulation can restore NK cell cytotoxicity. NK cell-specific chimeric antigen receptors enhance CAR NK cell functions and anti-tumor activity, further supporting degranulation as a targetable endpoint.
Glioblastoma and solid tumor models
Cytokines impact natural killer cell phenotype and functionality against glioblastoma in vitro, indicating that degranulation can be modulated in the context of brain tumors. These findings support the use of NK cell degranulation assays in preclinical solid tumor research.
Cryopreservation and NK cell manufacturing
Pretreatment with IL-15 and IL-18 rescues natural killer cells from granzyme B-mediated apoptosis after cryopreservation, which is relevant to the manufacturing and functional preservation of NK cell products. Maintaining degranulation capacity after cryopreservation is a key quality attribute for NK cell therapies.
From natural killer cell degranulation-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is a candidate gene required for NK cell degranulation? | CRISPR knockout in NK cell lines or primary NK cells |
| Does a specific mutation affect Rab27a activation and degranulation? | Point mutation knock-in of RAB27A |
| Can a CAR enhance NK cell degranulation? | Knock-in of NK cell-specific CAR |
| Does overexpression of a chemokine enhance NK cell infiltration? | Overexpression of CXCL11 in tumor or NK cell models |
| Does cytokine pretreatment preserve degranulation after cryopreservation? | IL-15/IL-18 pretreatment followed by CD107a assay |
| Does checkpoint blockade enhance NK cell cytotoxicity? | CD155 blockade in co-culture with osteosarcoma cells |
How to Study the natural killer cell degranulation Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CD107a flow cytometry | Surface exposure of CD107a as a marker of degranulation | Quantifying NK cell activity |
| Cytokine pretreatment assay | Effect of IL-15/IL-18 on NK cell function | Rescuing NK cells after cryopreservation |
| CRISPR knockout | Loss-of-function effect on degranulation | Testing candidate gene requirement |
| Point mutation knock-in | Effect of specific residues on Rab27a activation | Dissecting MADD-Rab27a signaling |
| Tumor co-culture | NK cell-mediated cytotoxicity against tumor cells | Osteosarcoma and hepatocellular carcinoma models |
| CAR engineering | Enhanced NK cell function and anti-tumor activity | CAR NK cell development |
| Cytokine profiling | NK cell phenotype and functionality against glioblastoma | In vitro glioblastoma studies |
| Granzyme B apoptosis assay | Apoptosis of NK cells after cryopreservation | NK cell manufacturing |
CD107a degranulation assay
CD107a (LAMP-1) surface exposure is a functional marker for the identification of natural killer cell activity and is the standard readout for NK cell degranulation. This assay can be combined with target cell co-culture to quantify the magnitude of degranulation.
Cytokine and metabolite modulation studies
Cytokines impact natural killer cell phenotype and functionality, and pretreatment with IL-15 and IL-18 can rescue NK cells from granzyme B-mediated apoptosis after cryopreservation. Such studies typically combine cytokine treatment with functional degranulation assays.
Genetic perturbation with CRISPR
MADD regulates natural killer cell degranulation through Rab27a activation, a finding enabled by genetic perturbation approaches. CRISPR knockout or point mutation of candidate genes followed by CD107a staining allows causal testing of degranulation regulators.
Tumor co-culture and checkpoint blockade
CD155 blockade enhances allogeneic natural killer cell-mediated antitumor response against osteosarcoma, and NK cell-specific CARs enhance CAR NK cell functions. These models integrate degranulation assays with tumor cell killing readouts.
How CRISPR Can Be Used to Study GO:0043320 natural killer cell degranulation
Knockout
CRISPR knockout of candidate genes such as MADD or RAB27A in NK cells can test their requirement for natural killer cell degranulation, as demonstrated by the regulation of degranulation through Rab27a activation. Knockout models are essential to establish causality in the degranulation pathway.
Point Mutation
Point mutation knock-in can be used to dissect specific residues required for Rab27a activation and downstream degranulation, building on the finding that MADD regulates NK cell degranulation through Rab27a activation. Such models refine mechanistic understanding beyond simple loss-of-function.
Knock-in
Knock-in of NK cell-specific chimeric antigen receptors enhances CAR NK cell functions and anti-tumor activity, illustrating how targeted insertion can boost degranulation-related cytotoxicity. Knock-in approaches also enable tagging of granule proteins for imaging.
Overexpression
Overexpression of chemokines such as CXCL11 can enhance natural killer cell infiltration and tumor control, as shown in hepatocellular carcinoma models. Overexpression models help identify sufficiency of a gene for enhancing NK cell degranulation and anti-tumor activity.
How EDITGENE Supports natural killer cell degranulation Research
Researchers studying natural killer cell degranulation-related genes often need to determine whether a candidate gene is causally involved in granule exocytosis, whether a specific mutation alters Rab27a-dependent trafficking, or whether engineered receptors can enhance cytotoxicity. EDITGENE provides the CRISPR cell model and screening services required to answer these questions with rigor and reproducibility.
Contact EDITGENE today to design your custom CRISPR model for natural killer cell degranulation research.
Frequently Asked Questions About natural killer cell degranulation
What is natural killer cell degranulation?
Natural killer cell degranulation (GO:0043320) is the regulated exocytosis of secretory granules containing preformed mediators such as perforin and granzymes by a natural killer cell.
What is GO:0043320?
GO:0043320 is the Gene Ontology identifier for natural killer cell degranulation, a biological_process describing cytotoxic granule exocytosis by NK cells.
What genes are involved in natural killer cell degranulation?
Key genes include PRF1, GZMB, LAMP1, RAB27A and MADD, with MADD regulating degranulation through Rab27a activation.
How is NK cell degranulation measured?
CD107a (LAMP-1) surface exposure is a functional marker for the identification of natural killer cell activity and is widely used to measure degranulation.
What is the role of Rab27a in NK cell degranulation?
Rab27a is a small GTPase that controls secretory granule trafficking and exocytosis, and MADD regulates NK cell degranulation through Rab27a activation.
Do cytokines affect NK cell degranulation?
Yes, cytokines impact natural killer cell phenotype and functionality, and pretreatment with IL-15 and IL-18 rescues NK cells from granzyme B-mediated apoptosis after cryopreservation.
Can CD155 blockade enhance NK cell degranulation?
CD155 blockade enhances allogeneic natural killer cell-mediated antitumor response against osteosarcoma, supporting enhanced NK cell cytotoxicity.
How do CAR NK cells relate to degranulation?
NK cell-specific chimeric antigen receptors enhance CAR NK cell functions and anti-tumor activity, which includes improved cytotoxic function.
What diseases are linked to NK cell degranulation?
NK cell degranulation is linked to cancer immunotherapy, including hepatocellular carcinoma, glioblastoma and osteosarcoma.
How can CRISPR help study NK cell degranulation?
CRISPR knockout, point mutation, knock-in and overexpression models allow causal testing of genes such as MADD and RAB27A in degranulation.
Conclusion
GO:0043320 natural killer cell degranulation is the regulated exocytosis of cytotoxic granules containing perforin and granzymes by NK cells, and it is the central effector mechanism of NK cell-mediated cellular cytotoxicity. Its measurement by CD107a exposure and its regulation by Rab27a, MADD, cytokines and checkpoint molecules make it a tractable and clinically relevant process. CRISPR-based models, including knockout, point mutation, knock-in and overexpression, together with library screening and bioinformatics, provide the tools needed to dissect and therapeutically harness NK cell degranulation.
References
- 1. Prager I et al.. 2019. Mechanisms of natural killer cell-mediated cellular cytotoxicity.. J Leukoc Biol 105(6):1319-1329 PMID: 31107565
- 2. Alter G et al.. 2004. CD107a as a functional marker for the identification of natural killer cell activity.. J Immunol Methods 294(1-2):15-22 PMID: 15604012
- 3. Zhang M et al.. 2025. Gut microbial metabolite butyrate suppresses hepatocellular carcinoma growth via CXCL11-dependent enhancement of natural killer cell infiltration.. Gut Microbes 17(1):2519706 PMID: 40576244
- 4. Medlyn MJ et al.. 2024. MADD regulates natural killer cell degranulation through Rab27a activation.. J Cell Sci 137(7) PMID: 38506245
- 5. Berjis A et al.. 2024. Pretreatment with IL-15 and IL-18 rescues natural killer cells from granzyme B-mediated apoptosis after cryopreservation.. Nat Commun 15(1):3937 PMID: 38729924
- 6. Sivonen M et al.. 2023. Cytokines impact natural killer cell phenotype and functionality against glioblastoma in vitro.. Front Immunol 14:1227064 PMID: 37841273
- 7. Cho MM et al.. 2025. CD155 blockade enhances allogeneic natural killer cell-mediated antitumor response against osteosarcoma.. J Immunother Cancer 13(4) PMID: 40234092
- 8. Pan C et al.. 2025. Natural killer cell-specific chimeric antigen receptor enhances CAR NK cell functions and anti-tumor activity.. Theranostics 15(17):9344-9358 PMID: 41280875
